Miran Aswad

ORCID: 0000-0002-5492-6074
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Cannabis and Cannabinoid Research
  • Immune cells in cancer
  • Phagocytosis and Immune Regulation
  • Pediatric health and respiratory diseases
  • Asthma and respiratory diseases
  • Pharmacological Receptor Mechanisms and Effects
  • COVID-19 and Mental Health
  • COVID-19 Clinical Research Studies
  • Berberine and alkaloids research
  • Natural product bioactivities and synthesis
  • Computational Drug Discovery Methods
  • Biochemical and Structural Characterization
  • Respiratory and Cough-Related Research
  • Toxin Mechanisms and Immunotoxins

Rambam Health Care Campus
2021-2024

University of Haifa
2013-2017

Western Galilee Hospital
2017

Cytokine storm refers to the dysregulated production of inflammatory mediators leading hyperinflammation. They are often detrimental, and worsen severity COVID-19 other infectious or diseases. Cannabinoids known have anti-inflammatory effects but their possible therapeutic value on cytokine storms has not been fully elucidated. In vivo ex studies were carried out investigate high-THC high-CBD extracts in immune cells. Significant differences between observed. Subsequent experiments focusing...

10.3389/fimmu.2022.875546 article EN cc-by Frontiers in Immunology 2022-05-16

The resolution of acute inflammation is hallmarked by the apoptotic death inflammatory polymorphonuclear (PMN) cells, followed their clearance macrophages. In turn, resolution-phase macrophages exert reduced proinflammatory cytokine production, termed immune silencing. this study, we found that atypical chemokine receptor D6 plays an important and scavenging-independent role in promoting macrophage-mediated resolution. D6(-/-) mice displayed increased numbers (2.2-fold increase), but not...

10.1096/fj.11-194894 article EN The FASEB Journal 2012-05-31

Abstract The engulfment of apoptotic polymorphonuclear cells (PMN) during the resolution inflammation leads to macrophage reprogramming culminating in reduced proinflammatory and increased anti-inflammatory mediator secretion. atypical chemokine receptor D6/ACKR2 is expressed on PMN plays an important role regulating properties after engulfment. In this study, we found that inflammatory CCL5 mostly retained (75%) zymosan A peritonitis mice. Moreover, secreted by resolution-phase macrophages...

10.4049/jimmunol.1502542 article EN The Journal of Immunology 2017-07-04

Background/Objectives: Asthma is a chronic inflammatory disorder of the airways affecting over 10% global population. It characterized by airway inflammation, mucus hypersecretion, and bronchial hyperresponsiveness, driven predominantly type 2 helper T cells (Th2) innate lymphoid (ILC2s) in subset patients. However, significant portion asthmatic individuals present with "type 2-low" asthma, often refractory to standard inhaled corticosteroid (ICS) therapy. Therefore,...

10.20944/preprints202409.0963.v1 preprint EN 2024-09-12

Asthma is a chronic inflammatory disorder of the airways affecting over 10% global population. It characterized by airway inflammation, mucus hypersecretion, and bronchial hyperresponsiveness, driven predominantly type 2 helper T cells (Th2) innate lymphoid (ILC2s) in subset patients. However, significant portion asthmatic individuals present with "type 2-low" asthma that often refractory to standard inhaled corticosteroid (ICS) therapy. Therefore, developing innovative therapeutic...

10.3390/ph17101382 article EN cc-by Pharmaceuticals 2024-10-17

Abstract The engulfment of apoptotic leukocytes (efferocytosis) by macrophages during the resolution inflammation is essential for homeostasis and results in macrophage reprogramming/immune-silencing. Here, we show CD11bhigh convert to CD11blow ones stop efferocytosing PMN after reaching an threshold vivo. In addition, are distinct from either M1 or M2 their protein expression profile display pro-resolving properties, such as diminished responses different TLR ligands ex vivo propensity...

10.4049/jimmunol.190.supp.112.12 article EN The Journal of Immunology 2013-05-01
Coming Soon ...